Project 3: Repurposing Ceritinib for Ovarian Cancer Therapy

Project: Research project

Project Details

Description

ABSTRACT – PROJECT 3 The 5-year survival for advanced high-grade serous ovarian cancer (HGSOC) is
StatusActive
Effective start/end date9/1/218/31/24

Funding

  • National Cancer Institute: $237,156.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.